Oseltamivir Phosphate Powder, For Suspension
Product Images NDC 0093-8180

2 FDA label images from Teva Pharmaceuticals Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate (NDC 0093-8180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

Structural Formula (Image 1)
Chemical structure of Oseltamivir Phosphate, showing its molecular formula C16H28N2O4·H3PO4 and molecular weight 410.40.*
FDA Label Image

1 (Image 2)

1 (Image 2)
Label for Oseltamivir Phosphate for Oral Suspension 6 mg/mL powder for suspension, manufactured by Teva Pharmaceuticals USA, Inc. The label includes preparation instructions, storage guidelines, and pharmacist notes. The package is for a 60 mL usable volume after constitution and contains regulatory and barcode information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.